L

Liminatus Pharma Inc
D

LIMN

20.000
USD
5.53
(38.22%)
مغلق
حجم التداول
78,671
الربح لكل سهم
0
العائد الربحي
-
P/E
-127
حجم السوق
520,292,660
المقالات

العنوان: Liminatus Pharma Inc

القطاع: Healthcare
الصناعة: Biotechnology
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towardscolorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.